Sign in
CompletedNo phase

Haemophilus Influenzae Pneumonia in Adults

Key facts

Who runs it
Assistance Publique - Hôpitaux de Paris
Where
France12 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
203 people enrolled
Started
26 Jul 2024
Ended
1 Sept 2024
Type of study
Observational
Treatments tested
  • Collection of data from the patient's medical file
Record updated
15 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Acute respiratory symptoms: cough and/or dyspnea and/or purulent sputum or worsening of the color of the sputum for patients with chronic respiratory pathology, chest pain, desaturation defined by saturation < 95% in ambient air
  • Inflammatory syndrome: fever ≥ 38.5°C or CRP ≥ 30 mg/L
  • Pulmonary imaging (x-ray or CT scan) compatible with pneumonia
  • Good quality respiratory sample (for cytobacteriological examination of sputum (CBES) : leukocytes > 25/mm3 and cells < 10/mm3) positive in culture for H. influenzae at a significant threshold (for CBES ≥ 107 CFU/mL, for "standard" bronchial aspirate ≥ 105 CFU/mL, for protected bronchial aspiration ≥ 103 CFU/mL, for bronchoalveolar lavage ≥ 104 CFU/mL)
  • Respiratory antibiotic therapy started by the clinician

Who cannot take part

  • Age < 18 years
  • Opposition formulated (following receipt of the study information note)
  • Legal protection measure (impossibility of collecting non-opposition)
  • Ventilator-associated pneumonia (VAP)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Haemophilus influenzae is a Gram-negative coccobacillus capable of colonizing and infecting the human respiratory tract.

Read full original descriptionShow less

In the adult population, patients with an abnormality of their mucociliary epithelium and a deficiency in innate or adaptive immunity are particularly exposed.

The Infectious and Tropical Diseases department of Necker-Enfants Malades hospital has noted a recent increase in the number of cases of respiratory infections due to H. influenzae, with a high frequency of early relapses and recurrences despite appropriate treatment.

The research focuses on lower respiratory infections (pneumonia) caused by Haemophilus influenzae in adults, excluding pneumonia acquired under mechanical ventilation linked to Haemophilus influenzae in patients in 13 AP-HP hospitals during 12 months, from 09/01/2022 to 08/31/2023.

The group in the trial

  • Patients

    Hospitalized patients for a Haemophilus influenzae pneumonia in 13 AP-HP hospitals between 09/01/2022 to 08/31/2023.

    Treatment: Collection of data from the patient's medical file

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Retrospective Hospital Study of Haemophilus Influenzae Pneumonia in Adults: Relapse and Severity
Record updated
15 June 2026